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Abstract This consensus article reviews the various aspects
of the non-pharmacological management of osteoporosis,
including the effects of nutriments, physical exercise,
lifestyle, fall prevention, and hip protectors. Vertebroplasty
is also briefly reviewed. Non-pharmacological management
of osteoporosis is a broad concept. It must be viewed as
an essential part of the prevention of fractures from
childhood through adulthood and the old age. The topic
also includes surgical procedures for the treatment of
peripheral and vertebral fractures and the post-fracture
rehabilitation. The present document is the result of a
consensus, based on a systematic review and a critical
appraisal of the literature. Diets deficient in calcium,
proteins or vitamin D impair skeletal integrity. The effect
of other nutriments is less clear, although an excessive
consumption of sodium, caffeine, or fibres exerts negative
effects on calcium balance. The deleterious effects of
tobacco, excessive alcohol consumption and a low BMI
are well accepted. Physical activity is of primary
importance to reach optimal peak bone mass but, if
numerous studies have shown the beneficial effects of
various types of exercise on bone mass, fracture data
as an endpoint are scanty. Fall prevention strategies
are especially efficient in the community setting, but
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DOI 10.1007/s00198-011-1545-xless evidence is available about their effectiveness in
preventing fall-related injuries and fractures. The efficacy
of hip protectors remains controversial. This is also true
for vertebroplasty and kyphoplasty. Several randomized
controlled studies had reported a short-term advantage of
vertebroplasty over medical treatment for pain relief, but
these findings have been questioned by recent sham-
controlled randomized clinical studies.
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Introduction
Osteoporosis is a chronic disease affecting one in three
women and one in five men over the age of 50 years [1].
Osteoporotic fractures are associated with high morbidity,
increased mortality risk, and major economical impact [2].
In the field of osteoporosis, the medical literature frequently
reports data from large randomized controlled trials
describing impressive drug-induced reduction of fracture
risk [3]. The availability of most of these drugs makes it
easy for the clinician to find an appropriate treatment for
most patients. Unfortunately, in the daily practice, osteo-
porosis treatment too often consists of drug prescription,
without any other preventive or therapeutic measure.
Besides drug prescription, non-pharmacological osteoporo-
sis management is an important and very broad concept. It
must be considered as part of the long-term prevention of
fractures, for men and for women, not only for postmen-
opausal women, but from childhood through adolescence,
pre- and perimenopause. This topic also includes the
surgical or invasive procedures for the treatment of
peripheral and vertebral fractures and the post-fracture
rehabilitation.
Lifestyle habits including calcium intake, general nutri-
tion and weight-bearing exercise during adolescence and
early adulthood contribute up to 20% of the observed
variation in the attainment of peak bone mass, as well as to
the rate of bone loss later in life [4, 5]. Falls in the elderly
are a major health problem, contributing to significant
increase in fracture risk, morbidity, and even mortality [6].
Fall prevention is consequently important in the elderly as
nearly one out of three adults living in the community falls
at least once each year, the risk being from far more
important for institutionalized patients or those with
neurologic disturbances [7]. In the context of patients with
high risk of falls, the use of hip protectors, aimed at
reducing the impact of falls onto the hip, has been
suggested as an effective strategy for hip fracture in nursing
home residents and potentially among other high-risk
individuals [8]. Vertebroplasty and kyphoplasty through
percutaneous injection of bone cement into fractured
vertebral bodies have been proposed for short- and long-
term pain management. For many years, results of these
surgical procedures have been evaluated positively in
retrospective non-randomized trials but results of recent
controlled studies are becoming available [9, 10].
The present document is the result of a national consensus,
based on a systematic review and a critical appraisal of the
literature. It aims at providing clinicians with an overview of
the currently available non-pharmacological measures for the
prevention and treatment of osteoporosis in men and
women.
Methods
We included randomized controlled trials (RCTs), meta-
analyses, and epidemiologic, retrospective, or prospective
studies, evaluating the non-pharmacological interventions
or environmental factors associated to an increase or a
decrease in the risk of osteoporotic fracture: diet (sodium,
potassium, phosphorus, protein, minerals, fibre, caffeine, or
vitamins intake); physical exercise or life style measures
(soda drinks or alcohol consumption, smoking, or sun
exposure) that have an effect on bone health; factors
associated to risk of falls and fall prevention strategies.
The efficacy of hip protector devices, of vertebroplasty and
kyphoplasty procedures, and the orthopaedic aspects of
orthopaedic fracture treatment have been similarly evaluat-
ed through a systematic search, from 1966 to 2010, in
MEDLINE and databases such as the Cochrane Controlled
Register, for citations of relevant articles. After this
extensive search of the literature, a critical appraisal of
the data was obtained through a consensus expert
meeting.
Nutrition and osteoporosis
As many other chronic conditions, osteoporosis (OP) has a
multifactorial origin. If it is admitted that at least 46–62%
of the variance in bone mineral density (BMD) depend of
genetic factors, consequently around 38–54% of the
variance of BMD can be modified by environmental
factors, in which nutrition plays a large part [11, 12].
Regarding the skeleton, nutrition could theoretically have a
direct and indirect role: firstly, to maximize bone strength
during growth through the amelioration of the peak bone
mass, by improving both the proteic compartment of bone
and the mineralization, and by decreasing the rate of bone
loss with ageing; secondly, to maintain the muscle strength
by restraining sarcopenia in elderly. Physical activity has
also a role, either isolated or in combination with nutrition.
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maximize bone gain chiefly at loaded sites [13, 14]. The
combined effect of nutrition and exercise has been less
studied for other nutriments. Moreover, during growth, an
interaction between environment, hormonal factors, nutri-
tion, ethnicity, sex, and genetics probably exists. Even
complicating more the study of the relationship between
nutrition and BMD, studies have shown a positive link
between maternal nutrition, body build, and fat stores during
pregnancy with whole body bone mineral content in children
at the age of 9, and even with adult bone mass [15]. A higher
whole body peak bone mass has been associated with breast-
feeding, suggesting the presence of other factors than
nutritive factors in human milk [16]. These direct and
indirect incentives of nutrition on BMD, bone structure, and
bone metabolism, as well as the weak correlation between the
nutritional intakes and their quantitative evaluation (e.g. food
frequency questionnaires; r=0.31–0.71) might only partly
reflect the long-term influence of feeding on bone. This
could explain the difficulty in determining precisely the role
of the nutritional intakes [17]. On the top of these
difficulties, it should be remembered that the influence on
the skeleton of some nutriments such as calcium is not linear,
but has a threshold effect probably variable across the age
groups [18]: lower than the threshold, there is some risk of
bone loss, around the threshold, bone maintenance is
observed, and above the threshold, there is no further
additive effect [18]. The role of calcium and vitamin D in
the treatment of OP has been recently reviewed in the last
BBC consensus [3]. Therefore their role will not be further
discussed. Suffice here to remember that the antifracture
efficacy is better for a daily intake of 1,000–1,200 mg
calcium and 800–880 IU vitamin D [19].
Excesses in sodium intake have a negative impact on
calcium balance by increasing the urinary calcium excre-
tion. There is, however, an interindividual differences in
salt sensitivity. Obligatory urinary calcium losses are
correlated with urinary sodium excretion [20]. For every
100 mmol of sodium excreted, approximately 1 mmol loss
of urinary calcium is observed [20]. It has been suggested,
however, that enough calcium in the diet could overcome
the salt deleterious effect. There could be 2-fold differences
in sodium-induced calciuria with low and high calcium
intakes. In a recent study, as compared with a low salt diet
(3.9 g/day), a high salt intake (11.2 g/day), corresponding
to upper intakes in postmenopausal women on a Western-
style diet provoked a significant increase in urinary calcium
excretion (+36%). The negative bone calcium balance was
not counteracted by a high calcium diet (1,284 mg/day).
Paradoxically, the negative bone calcium balance induced
by both high and low salt diets was less marked with a low
calcium intake. There was a significant increase in the
levels of parathyroid hormone (+11.4%) and of urinary N-
telopeptide (+19%) in response to the high sodium diet
[21].
In previous studies such as the Framingham study, in a
12-year follow-up, the risk of hip fracture over each 2-year
period was found significantly increased by the consump-
tion of ≥2.5 units of caffeine per day (one cup of coffee=
one unit of caffeine, and one cup of tea=0.5 unit of
caffeine) [22]. There is a theoretical explanation to the
fragilization of bone by caffeine intake: caffeine increases
urinary and faecal calcium losses and may provoke a
negative calcium balance in presence of a low calcium diet
[23]. Caffeine at a dose of 330 mg/day (i.e. four cups
(600 ml)) possibly might be associated with a modestly
increased risk of osteoporotic fractures (Hazards ratio, 1.20
(95% confidence interval (CI), 1.07–1.35)), compared with
a low caffeine intake (<200 mg/day) [24]. However, this
deleterious effect of caffeine seems to be offset by
increasing calcium intake (by 40 mg calcium for every
177.5 ml serving of caffeine-containing coffee, i.e. ∼1 cup)
[25]. This positive calcium effect greatly minimizes a
potential role for caffeine in BMD maintenance and bone
strength. No study has been done with decaffeinated coffee.
High phosphorus intakes are associated with lower levels
of calcium urinary excretion, but a slightly higher intestinal
calcium excretion. These opposite effects neutralize them-
selves and does not seem to negatively impact on calcium
balance [26, 27].
The role of protein intake remains controversial in the
development of osteoporosis. Excessive protein intake can be
responsible for a metabolic increase of acid production and
acid renal excretion, with increased calciuria potentially
favouring bone loss and hip fracture [26, 28]. Hypercalciuria
is not necessarily due to an increase in bone resorption.
Intestinal calcium absorption is indeed positively influenced
by protein intakes, probably secondary to insulin-like growth
factor-1 (IGF-1) production [29, 30]. On the contrary, in
postmenopausal women, but also in men, a positive
association between protein intakes and BMD has been
rather observed [28, 31]. In men and women, a mean loss of
BMD of −4.61% and −3.72% was observed in patients with
the lowest quartile of protein intake (17–53 g/day), versus a
loss of −2.32% and −1.11% in patients with the highest
quartile (84–152 g/day) at the femoral neck and spine,
respectively [31]. Munger et al. also observed that the risk of
hip fracture was not associated with calcium or vitamin D
intake, but was negatively related to total protein intake.
Proteins of animal and not vegetable origin apparently
accounted for this association. The relative risk for hip
fracture seemed to decrease paralleling the intake in animal
protein [32]. In another study, elderly women consuming
less than 66 g protein/d had lower values (1.3–2.2%) of
quantitative ultrasound of the heel (broadband attenuation
and stiffness measurements) and lower hip BMD (2.5–3.0%)
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Contrarily to these positive effects of protein intake on
BMD, Sellmeyer et al. showed in a prospective cohort study
that a high diet ratio of dietary proteins of animal origin over
vegetable protein could induce a higher rate of bone loss at
the femoral neck and an increased risk for hip fractures
(relative risk=3.7) in women aged more than 65 years [34].
This apparent deleterious effect of animal protein intake
could be counteracted by dietary or supplemental calcium
(500 mg as calcium citrate malate and vitamin D (700 IU)
per day) [35]. As far as the relationship between fractures
and protein intakes were concerned, some contradictory
results have been observed for the forearm fracture and hip
fractures [36]. A slightly higher risk for forearm fractures
was observed in women consuming more than 95 g per day
protein as compared with those consuming less than 68 g per
day (relative risk=1.22), whereas no association was found
with hip fracture [36]. This discrepancy could find its origin
in the fact that people with a higher protein intake have a
longer life expectancy possibly accounting for a higher
forearm fracture incidence [37]. Calcium intake can also
interfere with protein intake, a low dietary calcium poten-
tially blunting the positive effect of high protein intake [31,
35]. However, data from the 1999 to 2002 National Health
and Nutrition Examination Survey does not show any
association between total calcium intake and risk of fracture
in postmenopausal women. An inadequate dietary protein
intake in the presence of adequate total calcium intake does
not seem to confer any protection against fractures [38].
Once hip fracture has occurred, a 20-g protein supplemen-
tation could lead to a lower rate of general complications
such as bed-sores, infections, deaths, etc., and allow a shorter
stay in the hospital as shown in a study [39]. The observed
effect is probably due to a positive influence of dietary
proteins on the production of IGF-I [30]. Some studies
incriminated vegetarism for increasing bone remodelling and
decreasing BMD [40, 41]. The lower BMD observed might
not be clinically relevant, no difference in fracture risk
between vegetarians and nonvegetarians having been dem-
onstrated in a large study [42]. Vegetarianism should
therefore not be considered as a risk factor for osteoporotic
fracture. As this issue is that complicated, it seems
reasonable to recommend a balanced diet between vegetable
and animal proteins until further studies determine the most
appropriate regime. Indeed, it is not yet clearly demonstrated
that bone resorption induced by vegetables is dependent of
acid–base changes in protein intake [43]. Finally, protein
might play a role in maintenance of BMD by different
mechanisms, e.g. by increasing IGF-1, calcium absorption,
and muscle strength and mass, which all could benefit the
skeleton [44].
Potassium content, high in fruits and vegetables has a
protective effect against urinary calcium loss. However, this
positive effect can be completely offset by a low calcium
intake or a reduction in intestinal absorption. The best way
to preserve the body calcium economy is to encourage the
consumption of foods such as dairy products, which are
rich in calcium, proteins, phosphorus, and potassium [45].
In postmenopausal women, an increased intake of some
mineralsand vitamins could prove tobeable todecrease bone
loss [46]. This favourable effect has been suggested for
magnesium, boron (contained in dried-plums), vitamin C,
vitamin K, and fluor, but it is not commensurate to the effect
of calcium and vitamin D. Mononutrical supplements will
frequently be inadequate and preference should go to the use
of complete supplements or foods (e.g. dairy products) [45].
These supplements should be potentially useful mostly in
late postmenopause and in elderly people [46]. However,
their exact role in bone metabolism as compared with
calcium/vitamin D supplementation remains to be demon-
strated [47, 48].
High-fibre diets (≥30 g/day) could provoke a 20–30%
decrease in intestinal calcium absorption [49]. A lowered
plasma estradiol level has also been attributed to fibre
excess, but the effect on the skeletal integrity has not been
clearly settled [50].
Soy isoflavones are natural products structurally and
functionally related to 17 beta-estradiol. In vitro and animal
studies have suggested that phytoestrogens act on both
osteoblasts and osteoclasts through genomic and nongenomic
pathways [51]. In a recent meta-analysis including data from
1,240 postmenopausal women, daily ingestion of on average
82 mg soy isoflavones for 6 to 12 months was accompanied
by a significant increase in spine BMD (+2.38% (95% CI,
0.93–3.83; p=0.001)), compared with controls [52]. In a large
randomized, placebo-controlled trial, ipriflavone, another soy
isoflavone did not prevent bone loss nor affected biochemical
markers of bone remodelling in Western Caucasian postmen-
opausal women. Moreover, lymphocytopenia was observed in
a significant number of women [53]. However, several
epidemiological studies and clinical trials suggest that some
soy isoflavones have beneficial effects on bone turnover
markers and bone mechanical strength in postmenopausal
women [54]. It is possible that the varying effects of
isoflavones on spine BMD across trials might depend on
study characteristics, duration of therapeutic intervention (6
versus 12 months), origins of the patients (Asia versus
Western countries), race, and baseline BMD (normal BMD,
versus osteopenia, or osteoporosis). No significant effect has
ever been observed on femoral neck, total hip and trochanter
BMD. Further longer studies are necessary, because the role
of soy isoflavones in bone economy remains unclear. Their
long-term safety is still to be precisely stated. Use of calcium-
reinforced soy isoflavones could be considered.
Bone quality in adults mostly depends on the equilibrium
in bone remodelling. The latter is influenced by hormonal
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sufficient intake of macro- and micronutrients. The well
known,becausebetterandmoreextensivelystudied,elements
are calcium, proteins and vitamin D. Diets deficient in one of
the above-mentioned nutriments will certainly be at risk of
impairing skeleton integrity. However, it is possible that the
optimal health of the skeleton requires a good equilibrium
between all nutrients. As already mentioned above, it is
probable that mononutrient supplementation, as frequently
recommended in several diets will not necessarily lead to an
adequate bone quality [53].
Physical exercises
The main objective of physical exercise in the prevention or
treatment of osteoporosis is to reduce fracture incidence.
Unfortunately, no large, well-designed controlled trial
assessed, so far, the effect of exercise therapy with fracture
as an outcome. As a result, exercise interventions for
patients with osteoporosis mainly reported the reduction of
risk factor for fracture, i.e. a decrease in the propensity to
fall and/or an increase in BMD. Because mobility impair-
ments, such as reduced balance and muscle strength, are
risk factors for falls and fractures, they have also been used
as outcomes in clinical trials [55].
1. Target bone mineral density
In young, healthy subjects, it was shown that the type
(e.g. with land impact or not) and intensity (e.g.
endurance or not) of exercise have independent and
additive effects on bone density [56]s u g g e s t i n gt h a ta n y
physical activity could be of primary importance to
reach optimal peak bone mass, bone strength and bone
geometry. This is of primary importance from a
prevention point of view as an optimal BMD (as best
clinical surrogate for bone strength) before menopause is
of major importance to reduce the risk of fracture. It has
been suggested that pre and postmenopausal women
could have different responses (e.g. on BMD) to
exercise therapy [57].
From a primary prevention point of view, the
convergence of two factors greatly promotes bone health:
the critical period of bone accrual during childhood and
the importance of bone loading through specific physical
activity [58]. As a matter of fact, a lot of clinical trials
show that well-designed childhood physical activity
programmes (not to vigorous activities [59]) improve
BMD in children [58, 60], with different responses
between boys and girls [61, 62]. However, it should be
pointed out that there is little information if the benefits
are sustained into young adulthood.
A recent meta-analysis, performed among premeno-
pausal women, showed that combined protocols inte-
grating odd- or high-impact exercise with high-
magnitude loading (resistance exercises such a vertical
jumps or rope jumping, running, aerobic or step classes,
bounding exercises, agility exercises, and games where
movements included directional elements to which the
body is not normally accustomed), were effective in
increasing BMD at both lumbar spine and femoral neck
(weighted mean difference (WMD) 0.009 g/cm
2 95% CI
(0.002–0.015) and 0.007 g/cm
2 95% CI (0.001–0.013);
P=0.011 and 0.017, respectively). High-impact only
protocols were effective on femoral neck BMD (WMD
(fixed effect) 0.024 gcm(−2) 95% CI (0.002–0.027); P<
0.00001) [63]. In an individual patient data (IPD) meta-
analysis in premenopausal women showed that resis-
tance exercise was not significantly effective for
increasing or maintaining lumbar spine and femoral
neck BMD [64]. However, this IPD meta-analysis only
include 143 subject in the analysis.
Several high-quality studies showed that exercise
interventions can successfully maintain or increase
BMD in postmenopausal women, as shown in several
meta-analyses [65, 66]. In such population, the last
Cochrane review, updated in 2002, including 18 RCTs
meeting the inclusion criteria, shows that aerobics,
weight-bearing and resistance exercises were all effec-
tive on the spine BMD. The weighted mean differences
of the percentage change from baseline for the combined
aerobics and weight-bearing programme on the spine
was 1.79 (95% CI (0.58, 3.01)). Interestingly, the
analysed results showed walking not to be effective on
BMD of the spine but effective at the hip 0.92 (95% CI
(0.21, 1.64)). Aerobic exercise was effective in increas-
ing BMD of the wrist 1.22 (95% CI (0.71, 1.74)). More
recently, another meta-analysis aimed to assess the
effects of prescribed walking programmes on BMD at
the hip and spine in postmenopausal women [67]. It was
showed no significant change in spine BMD (WMD
0.007 g/cm
2 95% CI (−0.001 to 0.016); P=0.09)). At the
femoral neck, results were inconsistent, because of
heterogeneity, in showing a positive effect of walking
on BMD (WMD (random effects) 0.014 g/cm2 95% CI
(0.000 to 0.028); P=0.05). Insufficient data were
available for meta-analysis of the total hip site. At least,
in a IPD meta-analysis in postmenopausal women, no
effect of exercise on femoral neck BMD was observed
[68].
In subject with an increased risk of fracture (i.e. low
bone mineral density (osteoporosis and osteopenia) a
very recent systematic review concluded that bone
strength was improved by weight-bearing aerobic
exercise with or without muscle strengthening exercise
when the duration of the intervention was at least a year
[69].
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power, and balance)
Muscle weakness, lower power as well as balance
impairment, in elderly people, are associated with
physical function decline [65–67]. Osteoporotic women
also have a reduced muscular power and body balance
compared with women with normal bone mass [70].
These limitations represent major contributors to falls
and social, health and economic consequences are well
reported [68–71].
The large majority of the published studies investi-
gated the effectiveness of a progressive resistance
strength training (PRT) to reduce physical disability or
to improve balance, in a large variety of patients. Few
studies on PRT have been performed specifically in
osteoporotic subjects. PRT is widely accepted as an
appropriate modality for rehabilitation in elderly peo-
ple. PRT appears to be an effective intervention to
increase strength and has a positive effect on some
functional limitations [71, 72]. However, the effect of
PRT on physical disability, health related quality of live
and balance remains unclear. In a systematic review of
62 trials (n=3,674 subjects), Latham et al. showed that
PRT induces a strong positive effect on strength in
older subject (SMD 0.68; 95% confidence interval,
0.52–0.84) [71]. A modest effect was found on some
measures of functional limitations such as gait speed
(WMD 0.07 m/s; 95% CI 0.04, 0.09). No evidence of
an effect was found for physical disability (SMD 0.01;
95% CI, −0.14, 0.16). In another systematic review
evaluating PRT as a single intervention on balance
performance in older adults aged over 60 years, 29
studies were eligible for review [72]. Participants (n=
2,174 subjects) included healthy, community-dwelling,
mobility-limited, frail cohorts, and those with chronic
co-morbidities. Fourteen studies (15 tests representing
22% of all balance tests) reported significantly greater
improvements in balance performance following PRT
than in controls. Furthermore, some studies have
investigated the effectiveness of high-velocity and
high-power training (POW) to improve lower extremity
muscle power in community-dwelling older adults aged
over 65 years [73]. In contrast to traditional PRT, POW
specifically focuses on maximizing contraction velocity
and power development [73]. Fielding et al. [74]
compared the outcomes of POW and traditional slow
velocity progressive resistance training over 16 weeks
in women aged mean 73±1 years, and reported that
power training resulted in large improvements of leg
extensor power. Inconsistent effects of PRT on various
outcomes can partly be explained by heterogeneity of
cohort and balance tests, variability in methodology of
the balance test and sample size, inadequate dose of
PRT and/or compliance to training, or lack of statistical
power. Future studies are requested to investigate the
optimal training modalities (volume, duration, etc.)
required to elicit significant improvements of muscle
power, strength and functional performance in elderly
subjects who are at increased risk for subsequent
disability and fracture [73].
Besides PRT, other intervention has been assessed in
osteoporotic subject. The efficacy of home-based daily
exercise on muscle strength of the upper and lower
extremities was examined in elderly osteoporotic
women [75]. Grip strength and maximum walking
speed increased significantly in the intervention group
compared with the control group. Another study
evaluated the effect of 18-week progressive muscular
strength and proprioception training programme on the
muscle strength of the quadriceps, in prevention of falls
in postmenopausal women with osteoporosis [76]. The
intervention promoted a significant difference com-
pared with the control group for various outcomes
including muscular power (e.g. SF-36, Timed Up and
Go Test, maximum load [1-RM]) and the number of
fall.
At least, it is important to note that the positive
effect of exercise on muscle power, muscle strength,
body balance, gait, BMD, or fall number observed in
the majority of clinical trials does not automatically
translate into a reduction of fracture incidence. As a
matter of fact, these outcomes are only potential
surrogates for fracture reduction and an improvement
in these outcomes does not automatically translate into
fracture reduction. While a BMD loss over time, at the
level of the hip, was shown to be associated with an
increased fracture risk [77], an increase in BMD after
intervention is not systematically associated with a
reduction in fracture incidence. Improvement in BMD
observed with anti-osteoporotic drugs only explains
part of the reduction of fracture incidence [78].
In conclusion, some indirect evidence supports the
use exercise and training to reduce the risk of fracture.
Even if the optimal type, duration, and intensity remain
unclear and deserve researches, some practical recom-
mendations can be made based on the current knowl-
edge. General recommendation is that exercises should
be performed two to three times per week and must
include 15–60 min of aerobic exercises and a set of
strength training. The exercise intensity should be at
70–80% of functional capacity or maximum strength.
In the prevention of osteoporosis, high-impact exercise
(e.g. skipping and jogging) is important as it has the
greatest potential to improve BMD but low to medium
impact exercise (e.g. step aerobics and intermittent
jogging) is more appropriate for those not used to
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with osteoporosis, it is advised that any form of
strength training should be site specific (i.e. targeting
areas such as the muscle groups around the hip,
quadriceps, dorsi/plantar flexors, wrist extensors and
back extensors). Weight-bearing exercises should be
targeted to loading bone sites predominantly affected
by osteoporotic fracture. In all patients, these exercise
programmes should start at an easy level and be
progressive in terms of intensity and impact. Obviously,
the persistence to regular exercise and physical activity
is of primary importance.
Lifestyle
Epidemiological studies have identified a large number of
risk factors for osteoporotic fracture. These can be risk
factors related to bone strength, i.e. bone density, geometry
and/or quality, or factors independent of bone strength,
essentially related to risk for falls (one for review).
Amongst the identified risk factors only some are poten-
tially modifiable. Such risk factors that can be considered as
somehow related to lifestyle are listed in Table 1.
Low body weight or low BMI is a well-recognized risk
factor for fracture, whereas overweight and obesity have
generally been considered as protective [79, 80]. However,
recent evidence tends to challenge this view and suggests
that increased adiposity and obesity, which has been
associated with higher prevalence of vitamin D insufficien-
cy and in some studies also of secondary hyperparathy-
roidism [81, 82], can have a negative impact on indices of
bone strength and possibly on fracture risk [83–87]. Albeit
the available evidence thus suggests that a lifestyle that
helps maintaining a more ideal body weight is beneficial for
bone health, presently there is no evidence that interven-
tions aimed at gaining or losing weight in thin and obese
persons, respectively, can reduce fracture risk. In fact,
weight loss in obese subjects has been associated with
increased bone loss [88]. In this context, weight loss
following bariatric intestinal bypass surgery, but probably
not following gastric banding, has been associated with
prolonged elevations of the levels of biochemical markers
of bone turnover and with bone loss, also in absence of
vitamin D insufficiency or increase of serum PTH [82, 89,
90].
As to more specific lifestyle factors related to diet, the
potential adverse skeletal effects of low calcium intake,
high sodium intake and excessive caffeine consumption
have been addressed in the section on nutrition. The use of
carbonated soda drinks and more in particular of colas has
been associated with lower bone mass. Besides displace-
ment of more nutrient- and calcium-rich beverages, caf-
feine, and phosphoric acid content in colas have also been
implicated as contributing to the adverse skeletal effects
[13, 91].
Excessive alcohol consumption is generally recognized
as a secondary cause of osteoporosis and as a risk factor for
fracture [79]. Alcohol may interfere with bone metabolism
through direct toxic effects on osteoblasts and indirectly
through adverse skeletal effects of nutritional deficiencies
in calcium, vitamin D, and proteins that are prevalent in
heavy drinkers. However, increased fracture risk is
explained only for a minor part by increased bone fragility
and other factors, perhaps resulting in an increased risk for
falls, are involved. In a meta-analysis of three prospective
studies in a total of 5,939 men and 11,032 women, followed
for 75,433 person-years [92], alcohol consumption was
non-linearly associated with an increased fracture risk.
Consumption of 2 units or less (1 unit=10 g ethanol) per
Risk factor Related to bone strength, falls, other?
Dietary
Low body weight Bone strength
Overweight, obesity (?) Bone strength, (other?)
Low calcium intake Bone strength, (falls?)
High sodium intake Bone strength
Excess caffeine intake Bone strength
Excessive use of cola drinks Bone strength
Others
Excessive alcohol intake Bone strength, falls
Smoking Bone strength, other (?)
Low sun exposure Bone strength, falls
Use of hypnotic and sedative drugs Falls
Inappropriate housing conditions Falls
Physical inactivity Bone strength, falls
Table 1 Risk factors for
osteoporotic fractures related to
lifestyle
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whereas higher alcohol intake was associated both in men
and women with an increased risk of any fracture (risk ratio
(RR)=1.23; 95% CI, 1.06–1.43), any osteoporotic fracture
(RR=1.38; 95% CI, 1.16–1.65), or hip fracture (RR=1.68;
95% CI, 1.19–2.36). A similar threshold of around 2 units
per day for the association of alcohol intake and fracture
risk was reported in earlier studies [93, 94]. At variance
with the findings in some other studies, there were no
significant difference between gender for either the risk
ratios or threshold; above the threshold, there was a dose–
effect. Also at variance with some other studies reporting a
J-shaped association between alcohol consumption and
fracture risk, fracture risk was not higher in subjects
abstaining from alcohol use as compared with those
consuming 1or 2 units per day [79, 92]. However, it should
be noted that a number of both cross-sectional and
prospective studies failed to detect an increased fracture
risk associated with alcohol intake (see reference [1] for
review).
Smoking has adverse skeletal effects and current
smoking is associated with an increased fracture risk [79].
Albeit it has been reported that the adverse effects on BMD
are apparent after the age of 50 and increase with age [95],
smoking has been shown to also adversely affect bone
health in young individuals during bone maturation [96]. In
a meta-analysis of prospective studies involving 59,232
subjects (74% women) [97], current smoking was associ-
ated with increased risk of any fracture compared with non-
smokers (RR=1.25; 95% CI, 1.15–1.36) with the highest
risk observed for hip fracture (RR=1.84; 95% CI, 1.52–
2.22). The risk ratio was adjusted downward when account
was taken of BMD, but remained significant (RR=1.15 and
1.60 for any fracture and hip fracture, respectively); low
BMD accounted for only 23% of the increased risk for hip
fracture associated with current smoking. The fracture risk
was also adjusted downward when accounting for a lower
BMI in smokers, but risk ratios for any fracture and hip
fracture remained above unity and significant when adjust-
ing for either BMI or both BMI and BMD. Risk ratios
associated with smoking where higher in men compared
with women for any fracture and osteoporotic fracture, but
not for hip fracture. Risk ratio increased with age for any
fracture and osteoporotic fracture, but decreased with
advancing age for hip fracture. Subjects with a history of
smoking had a significantly higher fracture risk than never
smokers, but a lower risk than current smokers [97].
The mechanisms of the BMD-independent increased
fracture risk associated with smoking are unknown, but might
hypothetically involve altered bone geometry or material
property not captured by DXA evaluation [96], relative
physical inactivity and co-morbidity such as chronic lung
disease resulting in frailty and increased risk for falls.
In most countries, in particular in mid- and southern
Europe, the diet provides only a minor part of the vitamin D
requirement. A major source of vitamin D3 is synthesis in the
skin under influence of UV light, as is illustrated by the
marked seasonal variations in serum 25-hydroxyvitamin D
levels [98]. The reported very high prevalence of vitamin D
inadequacy in particular, but not exclusively, in elderly
subjects [98–100] indicates that a low dietary intake of
vitamin D is not compensated by sufficient synthesis in the
skin. This might in turn result from insufficient skin exposure
to the sunlight and a lesser efficacy of vitamin D synthesis in
de skin of elderly persons [98]. In urban areas, pollution may
contribute to the limitation of effective exposure to UV from
sunlight [101].
The fact that sun exposure tend to be generally low in
elderly subject is illustrated by the paradoxical finding in a
multi-country study in European elderly subjects of a positive
association between mean serum 25-hydroxyvitamin D levels
and degree of northern latitude [94]. This is most likely
explained by a generally low sun exposure, also in southern
European countries, and higher vitamin D availability in the
diet and/or as supplements in Northern European countries.
The low sun exposure in elderly persons is related to an
indoor style of living and/or clothing leaving little skin
exposed. In this regard, there are groups that are at higher
risk of vitamin D deficiency, already at younger age, as a
consequence of their habit to wear clothing that (nearly)
completely covers the skin for traditional cultural and/or
religious reasons [102, 103]; in these high-risk groups, high
prevalence of vitamin D deficiency during pregnancy is of
particular concern in view of the potential adverse skeletal
consequences for mother and child.
A Single randomized controlled trial in a psychogeriatric
institution in the Netherlands showed that UV irradiation of
1,000 cm
2 skin of the back of elderly subjects three times per
week with half the minimal erythematous dose was as
effective as a daily oral dose of 400 IU vitamin D3 to raise
serum levels of 25-hydroxyvitamin D and suppress secondary
hyperparathyroidism [104]. Although, this proof of concept
with UV irradiation approach is conceptually interesting, oral
supplementation remains a more practical solution to prevent
or treat vitamin D insufficiency. Moreover, present recom-
mendations suggest higher dosing of vitamin D supplements
and besides feasibility, the skin safety of the required
equivalent, more extensive UV irradiation might become an
issue. Along the same line, although more time spent outdoor
and moderate sun exposure should be encouraged in elderly
subjects in reasonably good general health, advising a marked
increase of exposure to sunlight might be a somewhat
confusing message, at odds with advices concerning the
prevention of skin cancer. Anyhow, it is unlikely that to
encourage increased exposure to sunlight could alleviate the
need for oral vitamin D supplementation.
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sedative drugs, and inappropriate housing conditions, four
important risk factors for fracture related to lifestyle, these
are discussed in the sections on exercise and prevention of
falls.
Although there undoubtedly exist interactions between
different lifestyle-related influences on bone health and
fracture risk, available information on such interactions is
rather limited. Nevertheless, it has been shown for several
of these that they contribute at least to some extent
independently to fracture risk, also independently from the
effect of low BMD and high age: i.e. low BMI, excess
alcohol consumption, and actual smoking [79].
Fall prevention
Between 28% and 35% of adults aged 65 years and older
and living in the community experience at least one fall
each year, and the annual fall prevalence increases with
ageing [105, 106]. Between 10% and 31% are recurrent
fallers [107, 108]. More importantly, community-dwelling
persons with dementia have the highest risk for falls with
prevalence rates up to 66%, with clear differences depend-
ing on the subtype of dementia (e.g. prevalence of falls in
Alzheimer’s disease 47%, vascular dementia 47%, Lewy
body dementia 77%, and Parkinson’s disease dementia
90%, respectively) [109].
For those living in nursing care facilities, the annual risk
of falls has been estimated to be also three times higher (i.e.
up to 70%), and 15% to 40% are recurrent with rates
between 1.1 and 1.4 per person per year for non-
psychogeriatric residents and between 2.1 and 2.4 per
person per year for psychogeriatric residents [107, 110].
But falls represent a frequent and serious problem in
hospitals as well, with a variability in the incidence of falls
depending on ward type and hospital population (between
2.2 and 17.1 falls per 1,000 patient days). Patients most
likely to fall are older inpatients: approximately 2% to 12%
of all patients experience at least one fall during their
hospital stay, but this proportion may increase to 11.9% and
24.8% in geriatric wards and to even 46% in stroke
rehabilitation units, respectively [111–115].
Falls in older persons are associated with considerable
mortality and morbidity. Unintentional injuries are the fifth
most important cause of death in people aged 75 and over
[106, 116]. Falls are the commonest cause of these
unintentional injuries in this age group: 30–50% of falls
result in minor trauma, 10–15% lead to serious injuries with
around 5–10% resulting in fracture, and 1–2% of these
being hip fractures [106]. The risk for (additional) injuries
increases when fallers are unable to rise without help and
when lying on the floor for a long time. Between 50% and
80% of older persons are unable to get up after at least one
fall, with the higher percentages reported in the very old
population (age 90 years and over). Up to 30% are lying on
t h ef l o o rf o ra nh o u ro rm o r e ,l e a d i n gt os e r i o u s
complications such as pressure sores, dehydration, hypo-
thermia, rhabdomyolysis, admission to hospital and long-
term care, and death [117, 118].
When hospitalized, other consequences are impaired
rehabilitation and functional decline, and increased need of
being institutionalised, e.g. a 3-fold risk for falling without
a serious injury and a 10-fold risk for a serious fall injury
[119]. Although not all falls lead to injuries, psychological
consequences such as fear of falling are substantial and may
lead to loss of confidence, fear of dependence, social
isolation, depression, and increased risk of falling [120]. In
community-dwelling older persons (fallers and also non-
fallers), fear of falling ranges from 20% to 85% and from
15% to 55% for associated avoidance of activity, respec-
tively, with higher rates associated with higher age, female
gender, fair and poor perceived general health, and multiple
falls [121].
As in all major geriatric syndromes, multiple risk factors
are involved in falls with chronic predisposing and acute
precipitating factors and interactions playing a crucial role.
Older persons with a precarious physiological and physical
balance have the potential to fall from seemingly minor
physiologic, intrinsic, and/or extrinsic risk factors; and the
greater the number of risk factors the greater the risk for falls
[122]. The most important intrinsic risk factors are: previous
falls, decreased muscle strength (upper or lower extremity),
gait and balance deficits, dizziness and orthostasis, visual
impairment, depression, functional and cognitive impair-
ment, low body mass index, urinary incontinence, chronic
musculoskeletal pain, female sex, and being 80 years and
older. Interactions between medications (e.g. polypharmacy),
psychotropic medications, and environmental risks (e.g.
loose rugs, insufficient lighting) have been identified as
major extrinsic risk factors [122–125]. Importantly, fear of
falling is not only a consequence of falling as noted above,
but also an important psychological risk factor for falls. Fear
of falling may lead to restriction of physical activities and
social participation and, as a consequence, increase the risk
for physical frailty and falls [126].
All these risk factors have been identified in a variety of
settings and almost always in the general older population.
Until recently, no high-quality studies have examined risk
factors for falling specific to dementia. In the largest
prospective study to date, Allan and colleagues identified
non-modifiable risk factors such as a diagnosis of Lewy
body disorder, longer duration of dementia and previous
history of falls or recurrent falls. More importantly, they
also identified potentially modifiable risk factors such as
use of cardioactive medications, autonomic symptoms,
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itation of physical activity [109].
Although there is substantial evidence that fall preven-
tion strategies reduce the number of falls and risk of falling
in the community setting, and preliminary evidence for the
residential and acute hospital setting, less evidence is
available about their effectiveness in preventing fall-
related injuries (e.g. sprains, bruises, and head-injuries)
and fractures (e.g. arm and hip fractures) [110, 122, 127,
128]. Despite this, clinicians should use an integrated
approach for fall and fracture prevention since many of
the previous mentioned risk factors for falls have been
shown to increase fracture risk as well [105, 122].
For community-dwelling older adults, single as well as
multifactorial fall prevention strategies have been shown to
effectively reduce falls in older adults.
Single-fall prevention strategies
In single-fall prevention strategies, physical therapy, and
exercise have been the most investigated interventions, and
various reviews and meta-analyses support the use of Tai
Chi, progressive balance, and gait and strength training;
however, evidence about endurance and flexibility training
is inconclusive [122, 127–129]. A meta-analysis of muscle
strengthening and balance retraining exercises individually
prescribed and delivered at home to older women and men
(age 65 to 97 years) showed a reduction in the number of
falls and fall-related injuries by 35% (RR=0.65; 95% CI,
0.57–0.75 and RR=0.65; 95% CI, 0.53–0.81, respectively)
and these exercises were of most benefit to those
individuals aged over 80 years and showed a higher
absolute reduction in injurious falls in those with a history
of a previous fall [130]. Similarly, the most recent Cochrane
meta-analyses showed that programmes delivered at home
and containing at least two exercise components are
effective: group exercise (RR=0.78; 95% CI, 0.71–0.86;
RR=0.83; 95% CI, 0.72–0.97), Tai Chi (RR=0.63; 95%
CI, 0.52–0.78; RR=0.65; 95% CI, 0.51–0.82), and indi-
vidually prescribed exercise (RR=0.66; 95% CI, 0.53–0.82;
RR=0.77; 95% CI, 0.61–0.97) have all been shown to
reduce the rate of falls and the risk of falling, respectively
[128]. However, in contrast to the meta-analysis of
Robertson et al. [130], subgroup analyses in the Cochrane
meta-analyses [128] could not find any difference between
studies targeting people with known falls risk, or people
who had not been enrolled on the basis of risk factors;
exercises were effective in both subgroups. Finally, phys-
ical therapy and exercise seem to be even more effective
when embedded in a multifactorial fall prevention strategy
(see below), but optimum type, frequency, duration, and
intensity of exercise as well as strategies to ameliorate
adherence remain to be clarified [105, 122, 128, 129].
Home safety assessment and modification has been
tested in a substantial number of studies and the most
recent Cochrane meta-analysis found this kind of single
strategy not effective when used in older adults at low fall
risk (RR=0.90; 95% CI, 0.79–1.03), however it reduced
significantly the rate of falling (RR=0.56; 95% CI, 0.42–
0.76) and fall risk (RR=0.78; 95% CI, 0.64–0.95) among
older adults with previous falls or fall risk factors such as
severe visual impairment, respectively [128].
One particular single-fall preventive strategy tested in a
number of large studies is vitamin D supplementation, with
or without calcium. A thorough discussion of the effects of
vitamin D is beyond the scope of this paper. However, a
recent meta-analysis by Bischoff-Ferrari [131] concluded
that doses of 700 to 1,000 IU supplemental vitamin D a day
could reduce falls by 19% or by up to 26% with vitamin
D3. This benefit may not depend on additional calcium
supplementation, was significant within 2–5 months of
treatment, and extended beyond 12 months of treatment.
Reducing the number of medications seems to be
another important single strategy to reduce falls given the
clear association between falls in older adults and the use of
sedatives and hypnotics, antidepressants, and benzodiaze-
pines [125]. A randomized controlled study evaluating the
effect of gradual psychotropic medication withdrawal
showed a 66% (RR=0.34; 95% CI, 0.16–0.74) reduction
for falls [132] and another cluster-randomized controlled
trial evaluating an educational and medication review and
feedback programme for general practitioners on use of
medicines showed a reduction of 39% (OR=0.61, 95% CI,
0.41–0.91) and 44% (OR=0.56; 95% CI, 0.32–0.96) in the
number of falls and the number of any kind of injurious
falls, respectively [133]. Medication review and removal or
adaptation of the regimen seems to be effective; however
more studies are needed and special attention will have to
go to individuals resuming their psychoactive medication
after withdrawal [122, 128].
Other promising single-fall prevention strategies have
been successfully tested in a limited number of studies:
cardiac pacing in older fallers with carotid sinus hypersen-
sitivity [134] and expedited surgery for first eye cataract
older adults [135]. However, older adults receiving second
eye cataract surgery did not benefit [136].
Multifactorial fall prevention strategies
Various multifactorial intervention strategies have been
tested in community-dwelling older adults. These preven-
tion programmes consist of an in-depth risk assessment of
several known fall risk factors and interventions based on
this risk assessment [127, 128, 137]. One typical example
of a multifactorial intervention programme can be found in
the Table 2. Chang and colleagues showed in their meta-
2778 Osteoporos Int (2011) 22:2769–2788Table 2 Example of a multidisciplinary mulifactorial intervention program: in-depth multifactorial assessment of known fall risk factors followed
by linked interventions (Adapted from Milisen et al. 2009)
Risk factor Assessment Evaluation criteria Interventions
Mobility impairment
(muscle weakness
and balance deficits)
Four-Test Balance Scale
a Inability to hold one of four
positions for 10 s
Referral to
physiotherapist (GPs)
Timed Chair Stand
b Inability to perform test within 14 s Education on importance
of exercising (nurses)
Functional reach
c Inability to reach further than 25 cm Individualized exercise program (PhysT)
Advise to use assistive devices (OccT)
Medication Medication count Polypharmacy (≥4 medications) Review and/or reduce medications (GPs)
Kind of medication Use of benzodiazepines, sedatives,
neuroleptics, antidepressants, digitalis,
diuretics, class IA antiarrhythmics
Education on the effect of
medications on falls (Nurses)
Referral to GP (PhysT)
Referral to GP (OccT)
Postural hypotension “Do you feel dizzy or lightheaded
when getting up from a chair, couch,
out of bed, or when bending?”
Reporting dizziness when getting
up or bending
Etiology and causal treatment (GPs)
Advise to prevent postural
hypotension (nurses)
Evaluation of fall in blood pressure (BP fall)
d Systolic BP fall >20 mmHg or diastolic
BP fall >10 mmHg on standing;
systolic BP≤90 mmHg on standing
Advise to prevent postural
hypotension (PhysT)
Advise to prevent postural
hypotension (OccT)
Vision Reporting difficulty with reading,
driving, watching TV
“Do you have difficulty with reading,
driving, or watching TV?”
Last checkup >1 year ago Referral to ophthalmologist (GPs)
Date of last checkup Difficulty using bifocal glasses Discussion of problem with family (Nurses)
Evaluation of bifocal glasses Score ≤4/10 Education on dangers of bifocal
glasses (PhysT)
Linear E chart
e Advise to consult ophthalmologist
once a year (OccT)
Feet and footwear Clinical evaluation of feet Foot disorders (e.g. in-grown nails,
calluses, presence of pressure points)
Treatment or referral to orthopaedic
surgeon (GPs)
Advise decent footwear (Nurses)
Clinical evaluation of footwear Unsteady shoes, open-back shoes,
high heels, slippery soles
Advise decent footwear (PhysT)
Advise decent footwear (OccT)
Environment and
behaviour
“Are there any factors in your house
that raises the risk for falls?”
Environmental risks (e.g. loose rugs,
insufficient lighting)
Referral to occupational therapist (GPs)
Checklist for home safety (nurses)
“Do you turn the light on when you
go to the bathroom at night?”
f
Inappropriate behaviour (e.g. standing
on chair or stepladder to get something)
Advise safe environment and
behaviour (PhysT)
Assessment of environment (OccT)
Fear of falling “Are you afraid of falling?”
Reporting fear of falling
“Do you limit your activity due
to fear of falling?”
Reporting restriction of activity as a
result of fear of falling
Education on risk factors for falls (GPs)
Information about personal
alarm system (nurses)
Education on getting up after a fall (PhysT)
Assess with Falls Efficacy
Scale-International (OccT)
GPs general practitioners, PhysT physiotherapist, OccT occupational therapist
aThe patient is asked to take the following four positions consecutively: stand with feet together, semi-tandem stand, tandem stand, and one-leg stand
bThe patient is asked to repeat the following action five times: stand up from a chair without using arms and sit back down again
cA metre stick is positioned horizontally on a wall, and the patient is asked to reach as far as possible in standing position and after bending forward
(physiotherapists only)
dPatient’s blood pressure is measured after more than 5 min in a supine position, immediately after standing, and 2 min after standing
eThe test is performed with the patient positioned 5 m from the chart; both eyes are tested together and the patient wears his/her glasses
fThe behavioural assessment consisted of three other questions regarding risky behaviour: “Do you perform unsafe activities such as hurrying to the door or
to the phone when it rings or using a chair or ladder to reach for things located above your head?”; “Do you wear unsteady shoes (e.g. slippers)?”; “Do you
perform other unsafe activities?”
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on both risk of falling (RR=0.82; 95% CI, 0.72 to 0.94)
and monthly rate of falling (RR=0.63; 95% CI, 0.49 to
0.83) [127]. In line with these findings, the most recent
Cochrane meta-analysis showed a significantly reduction in the
rate of falls (RR=0.75; 95% CI, 0.65–0.86); even when
excluding two outliers the results remained significant (RR=
0.82; 95% CI, 0.76–0.90). However, the Cochrane meta-
analysis could not confirm a significant reduction in risk of
falling (RR=0.95; 95% CI, 0.88–1.02). Also, there was no
effect on the risk of fracture (RR=0.70; 95% CI, 0.47–1.04)
[128]. Although there was no evidence in the Cochrane meta-
analysis that assessment and monitoring and follow-up of
interventions was more effective than assessment and
unmonitored referral or only advice, another recent meta-
analyses found only an effect on the number of fallers in trials
with higher intensity interventions (RR=0.84; 95% CI, 0.74
to 0.96) [137]. This indicates the need for a more careful
monitoring and follow-up to enhance compliance with
recommendations and provide more insight in the feasibility
of integrating fall prevention strategies into daily practice of
primary healthcare disciplines [123, 138, 139]. Gates et al.
were unable to assess fall rates, but again showed no effect on
fall-related injuries (RR=0.90; 95% CI, 0.68 to 1.20) [137].
With regard to nursing care facilities, a narrative review
concluded that multifactorial intervention programmes have
the potential to prevent falls [140]. Unfortunately, the two
most recent meta-analyses could not confirm this assump-
tion. Overall, both meta-analyses could not find a signifi-
cant reduction in the rate of falls or risk of falling [110,
141]. However, post hoc subgroup analyses in the
Cochrane review showed a significant decrease in the rate
of falls (RR=0.60; 95% CI, 0.51–0.72) and risk of falling
(RR=0.85; 95% CI, 0.77–0.95) when multifactorial inter-
ventions (that included exercises) where provided by a
multidisciplinary team; and this in contrast with multifac-
torial interventions initiated by single health professionals
which did not reduce the rate of falls (RR=1.11; 95% CI,
0.90–1.37) or risk of falling (RR=1.07; 95% CI, 0.94–1.23)
[110]. Importantly, a subgroup analysis of a limited number
of multifactorialinterventions provided bya multidisciplinary
team and reporting data on proximal femoral fractures,
showed a significant reduction in the risk of these fractures
(RR=0.48; 95% CI, 0.24–0.98).
In contrast with the established evidence for effective
exercise programmes in the community setting, results of
the meta-analyses relating to exercise prevention pro-
grammes as a single intervention in nursing care facilities
are inconsistent [110]. In fact, attention should be paid
when applying exercises to frail nursing home residents, as
frail residents might be less likely to benefit from exercises,
and exercises may paradoxically increase the risk of falls
and injuries in this vulnerable population [110, 142].
In a hospital setting, there is preliminary evidence for
effective falls prevention programmes, in general, with no
evidencehoweverinthe “acute”hospitalsetting.For instance,
inourownmeta-analyses,includingonlyhigh-qualitystudies,
we could not show an effect on number of falls (RR=0.82;
95% CI, 0.65–1.03) or number of fallers (RR=0.87; 95% CI,
0.70–1.08) [111]. Another meta-analysis, with broader
inclusion criteria than ours, showed only a minor effect on
the number of falls (RR=0.82; 95% CI, 0.68–0.99), but
again not on the number of fallers (RR=0.95; 95% CI, 0.71–
1.27) [37]. The most recent Cochrane meta-analysis showed
that multifactorial interventions (RR=0.73; 95% CI, 0.56–
0.96) and single supervised exercise interventions (RR=
0.44; 95% CI: 0.20–0.97) can both reduce the risk of falling,
with multifactorial interventions also reducing the rate of
falls (RR=0.69; 95% CI, 0.49–0.96). However, the total
number of participants in the single supervised exercise
analysis was small and, for all types of interventions, the
results were only positive in patients with prolonged hospital
stay (at least 3 weeks) or in subacute settings (6). More
importantly from the perspective of this paper, all meta-
analyses were inconclusive about effects on injuries [110,
111, 141].
Devices
Hip protectors
Because of the associated burden in terms of morbidity and
mortality, hip fractures are generally considered the most
dramatic complication of osteoporosis. In older individuals,
falls and other indicators of frailty become the dominant
determinant of hip fracture [143]. Reducing the impact of
falls onto the hip with the use of hip protectors may
therefore be an effective strategy for preventing fractures,
particularly in nursing home residents. An external hip
protector is a (polypropylene or polyethylene) shell that fits
around the hip. It is designed to absorb the energy from a
fall and especially to shunt the energy to the soft tissues
around the hip and keep the force on the trochanter below
the fracture threshold.
Numerous randomized controlled trials have examined
the effect of external hip protectors on the incidence of hip
fractures, but findings have been conflicting [144–154]. In
a number of studies, hip protectors did significantly reduce
the incidence of hip fractures [144, 145, 147, 148, 150]
some were borderline statistically significant (4, 11), and
other did not show statistical significance [149, 151, 153–
155]. In addition, several trials were small-sized, including
<200 participants [145, 147, 149, 150], and most positive
studies did not use individual randomization to assign
persons to the hip protector or control group [144, 146,
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use individual randomization, hip protectors were not
effective in preventing hip fractures [151, 153, 155]. The
different conclusions drawn from clustered and nonclus-
tered randomized trials of hip protectors underscore the
methodologic biases in the design and execution of cluster-
randomized trials [156].
One example of a well-designed trial was the Amsterdam
Hip Protector Study, a randomized controlled trial in which
561 institutionalized elderly persons at high risk for hip
fracture were randomized to the hip protector group or to the
controlgroupina1:1ratiowithameanfollow-upof70weeks
[153]. Compliance at unannounced visits declined from 61%
to 37% during follow-up. In the intervention group, 18 hip
fractures occurred versus 20 in the control group. At least
four hip fractures in the intervention group occurred while an
individual was wearing a hip protector. Both in univariate
and multivariate analyses, no statistically significant differ-
ence between the intervention group and control group was
found with regard to time to first hip fracture (hazard ratio
(HR), 1.05; 95% confidence interval [CI], 0.55–2.03). Even
the per protocol analysis in compliant participants did not
show a statistically significant difference between the groups
(HR, 0.77; 95% CI, 0.25–2.38). One of the strengths of the
Amsterdam Hip Protector Study—in addition to its use of
individual randomization—was its setting: 45 different
homes for the elderly and nursing homes in which nurses
had to supervise the wearing of the hip protectors, suggest-
ing that the results of this trial can be generalized to most
institutionalized elderly persons.
One of the more recent studies that further ignited
controversy about this type of intervention was the Hip
Impact Protection Project, published by Kiel and colleagues
[154]. In this multi-center, randomized controlled clinical
trial, 37 nursing homes were randomly assigned to having
residents wear a 1-sided hip protector on the left or right
hip, allowing each participant to serve as his or her own
control. The energy-absorbing/shunting hip protector was
selected based on its performance in a pilot study and
biomechanical testing that demonstrated superior capacity
to reduce peak impact force in simulated drop-weight
experiments. The hip protector was made of an outer layer
of polyethylene vinyl acetate foam, backed by a hard high-
density polyethylene shield, which in turn was backed by a
layer of polyethylene vinyl acetate foam. Garments with
pad pockets on 1 side were available in various sizes. Each
resident was provided as many garments as needed for use
around-the-clock, allowing for soilage, laundry turnaround
time, losses, and deterioration over time. Participants were
1,042 nursing home residents with a mean age of 85 years;
79% were women. After a 20-month follow-up (676
person-years of observation), the study was terminated
due to a lack of efficacy. The incidence rate of hip fracture
on protected versus unprotected hips did not differ (3.1%;
95% CI, 1.8–4.4% vs 2.5%; 95% CI, 1.3%–3.7%; P=.70).
For the 334 nursing home residents with greater than 80%
adherence to hip protector use, the incidence rate of hip
fracture on protected vs unprotected hips did not differ
(5.3%; 95% CI, 2.6%–8.8% vs 3.5%; 95% CI, 1.3%–5.7%;
P=.42), adding to the increasing body of evidence that hip
protectors, as currently designed, may not be effective for
preventing hip fracture [151, 153, 155].
In addition to the inconsistency of the results [144–154,
157] and the lack of documented cost-effectiveness [158],
one of the main concerns with external hip protectors is
poor compliance [159]. Most of the residents who
experienced a hip fracture in negative studies were not
wearing the protector at the time of the fall [149, 151, 153,
154]. Thus, adherence is a factor that could potentially be
improved with good results. In a systematic review by van
Schoor and colleagues [160], primary acceptance with hip
protectors varied around a median of 68% and, in those
accepting the device, compliance varied around 56%.
However, in most studies it was not very clear how
compliance was defined (e.g. average wearing time on
active days and during waking hours, number of user-days
per all available follow-up days, percentage falls with hip
protector) and how it was measured. The reasons most
frequently mentioned for not wearing hip protectors, were:
not being comfortable (too tight/poor fit); the extra effort
(and time) needed to wear the device; urinary incontinence;
and physical difficulties/illnesses. The authors concluded
that compliance is a complex issue in hip protector
implementation and that methods to improve compliance
should be developed, and their effectiveness tested [160].
Based on the studies that have been published, there is
likely to be continued debate and uncertainty about the
efficacy of hip protectors because of the heterogeneity of
findings, well-documented compliance issues, and potential
biases from clustered randomization designs. Nevertheless,
recent pooled analyses have suggested that two-sided
devices may potentially reduce the risk of hip fracture, at
least in institutionalized elderly [161]. And so it would
seem that, although available evidence does not allow firm
and final conclusions or recommendations, it may not be
appropriate to discount the potential benefit of this
intervention in a long-term care setting. Larger and more
costly clinical trials are required to definitively investigate
effectiveness of hip protectors. Consensus recommenda-
tions for future research include the following: the use of a
hip protector that has undergone adequate biomechanical
testing, the use of sham hip protectors, the conduct of
clinical trials in populations with annual hip fracture
incidence of at least 3%, a run-in period with demonstration
of adequate adherence, surveillance of falls and adherence,
and the inclusion of economic analyses [162].
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Vertebral compression fractures (VCFs) can lead to severe
vertebral deformity or hyperkyphosis, which in turn is
associated with significant back pain and back dysfunction
[163], functional impairment [164], loss of quality of life
[165] and even mortality [166]. Standard treatment of
painful VCFs is conservative non-surgical management
(NSM), consisting of bed rest, analgesics, and bracing.
However, in some patients, NSM fails to improve pain and
mobility, particularly in cases of chronic pain related to
kyphotic deformity [167]. Patients refractory to medical
therapy can be considered for vertebroplasty or balloon
kyphoplasty, two minimally invasive surgical approaches
developed for the management of symptomatic VCFs [168]
which are increasingly being proposed as effective and safe
[169, 170]. The insertion of bone cement (polymethylme-
thacrylate-based, PMMA, or calcium phosphate-based,
CaP) into the vertebra is thought to stabilize and reduce
the fracture and relieve pain.
Vertebroplasty includes the percutaneous insertion of a
needle through the pedicles into the vertebral body and the
injection of a bone cement (PMMA or CaP) into the
cancellous bone [171]. The cement will follow the path of
least resistance and the procedure is monitored directly
under fluoroscopic control. For balloon kyphoplasty,
cannulae placed percutaneously into the vertebral body
permit the insertion of two inflatable bone tamps (IBTs)
[172]. After removal of the IBTs, the pre-defined cavity is
filled with PMMA- or CaP [173] under low manual
pressure [174]. Like during vertebroplasty, the procedure
is monitored directly under fluoroscopy. Besides stabilizing
the fracture, balloon kyphoplasty also aims at restoring
vertebral body anatomy with height recovery and angular
deformity correction [175]. A thorough discussion of both
techniques is beyond the scope of this article, as a
systematic in-depth review on the topic by a dedicated
IOF Working Group has been submitted for publication (S.
Boonen, personal communication).
While a number of randomized controlled studies have
demonstrated acute advantage of vertebroplasty over
medical treatment in pain relief of VCFs [176, 177], these
findings have been questioned by recent sham-controlled
randomized clinical studies that could not confirm these
conclusions [178, 179], with no significant between-group
differences regarding pain reduction , quality of life or
physical functioning. In the first of these trials, 78 patients
with one or two painful osteoporotic fractures were
randomized to undergo VP or a simulated sham procedure
[178]. The primary outcome was overall pain score at
3 months, which decreased in both groups significantly
compared with baseline. Pain reduction was sustained in
both groups for 6 months. Similar improvements were seen
in both groups with respect to physical function, quality of
life, and perceived improvement in pain, even after
adjustment for baseline levels of previous vertebral frac-
tures and duration of symptoms. In the second single-blind
trial, 131 patients were randomly assigned to VP or a
simulated sham procedure [179]. The primary endpoints of
the study were scores in the modified Roland Morris
Disability Questionnaire and perceived back pain intensity
after 1 month. Both procedures had an immediate and
sustained improvement up to 1 month after the intervention,
although not statistically different between the two arms.
The improvements of other measures of pain, physical
function and quality of life (EQ-5D, SF-36 MCS, and PCS)
did not also differ between groups at 1 month. Unfortu-
nately, cross-over of patients in this study precluded longer
term randomized comparisons between groups. Neverthe-
less, both studies have questioned the value of vertebro-
plasty. In addition, hardly any data exist on the cost-
effectiveness of vertebroplasty [180] and the procedure
appears to have a high rate of cement extravasations with
an associated increased risk of pulmonary emboli and
compression of neural foramen [181].
The largest prospective controlled study performed so far
comparing minimally invasive surgery in VCFs and non-
surgical management was the Fracture Reduction Evalua-
tion Study, a multi-center randomized control trial in 300
patients with 5–6 weeks old VCFs comparing balloon
kyphoplasty with non-surgical management [182]. In this
trial, the primary outcome was the difference in change
from baseline to 1 month in the SF-36 physical component
summary in kyphoplasty-treated and control groups. At
1 month, patients quality of life was significantly improved
after balloon kyphoplasty compared with non-surgical
management (p<0.0001) and this difference was main-
tained up to 1 year. Back pain score (VAS score) decreased
more after kyphoplasty at 1 week (p<0.0001) and after
12 months (p<0.0034) compared with control; this im-
proved pain was concomitant with significantly fewer
kyphoplasty patients requiring opioid medications in the
first 6 months. Cases of cement extravasation were
asymptomatic. At 12 months, no between-group differences
were observed in the proportion of patients with new or
worsening radiographic vertebral fractures. Literature
reviews report a cement leakage rate of about 10% with
balloon kyphoplasty [183, 184]. Recent cost-effectiveness
analyses using quality-adjusted life years suggest that
balloon kyphoplasty may be a cost-effective treatment in
osteoporotic patients hospitalized with painful VCFs [185,
186].
In a number of prospective non-randomized studies and
one prospective randomized trial comparing VP with BKP
for treatment of osteoporotic VCFs [187–189], no signifi-
cant differences could be documented for pain relief up to
2782 Osteoporos Int (2011) 22:2769–27886 months. However, a blinded, randomized clinical trial
comparing vertebroplasty, balloon kyphoplasty and a sham
procedure is lacking to state definitely of the advantage of
one or the other procedure over conservative management.
To conclusively determine whether rates of subsequent
VCFs are higher among subjects undergoing balloon
kyphoplasty compared with those treated non-surgically or
with vertebroplasty would require a concurrently controlled
study in which risk factors for fracture are evenly
distributed across treatment groups.
Conclusions
It is likely that the optimal health of the skeleton requires an
adequate equilibrium between all nutriments. Interactions
between various nutriments, e.g. calcium and protein, and
between some nutriments and exercise or other lifestyle
habits much complicate the interpretation of studies aiming
at defining the importance of a particular nutriment.
Numerous studies have shown the beneficial effects of
various types of exercise on bone mass but data with
fracture as an endpoint are scanty. Physical activity is of
primary importance to reach optimal peak bone mass and
high-impact exercises combined with resistance exercises
can increase BMD in premenopausal women. Exercise
interventions can successfully maintain or increase BMD
also in postmenopausal women. The major benefit of
exercise in patients with osteoporosis may be in improving
muscle strength and coordination, which, in turn, decreases
the frequency of falls.
A low BMI is a well-recognized risk factor for fracture
but obesity can also have a negative impact on indices of
bone strength and possibly on fracture risk. Current
smoking and excessive alcohol consumption are associated
with an increased risk for fracture.
Muscle strengthening and balance retraining exercises
individually prescribed can reduce the number of falls and
fall-related injuries by 35%. Multifactorial fall prevention
programs are effective on both risk of falling and monthly
rate of falling. Results are less consistent in nursing care
facilities than in the community setting. Hip protectors are
designed to reduce the impact of falls onto the hip and to
prevent hip fracture. Numerous randomized controlled trials
have led to conflicting results. One of the main concerns
with external hip protectors is poor compliance and recent
pooled analyses have suggested that the regular use of two-
sided devices might reduce the risk of hip fracture in
institutionalized elderly.
Vertebroplasty and balloon kyphoplasty are used to
control back pain and to stabilize the vertebral fracture;
kyphoplasty also aims at restoring vertebral body anatomy.
These procedures are not without risks due to possible
cement extravasation. Limitations of both vertebroplasty
and kyphoplasty are the lack of long-term data and the
absence of conclusive comparative trials.
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